Genus Shares Drop 7% Despite 35% Profit Surge and £60m Buyback
Key Facts
In a move reflecting the disconnect between corporate performance and market reaction, Genus PLC shares dropped 7% to 162p following its latest financial update. This decline occurred despite the company reporting a robust 35% increase in adjusted profit before tax, which reached £100.2m for the fiscal year ending June 30, 2026. To further support shareholder value, the animal genetics group unveiled a new £60m share buyback program to be executed during the 2027 fiscal year.
According to analyst reports, the company benefited from strong growth in its PIC division and milestone payments from partners in China, helping adjusted operating profit rise by 25%. However, revenue saw a 2% dip on a currency-adjusted basis to £658.1m, which may have weighed on investor sentiment. Per market data, the board also increased the full-year dividend by 10% to 35.2p per share, while free cash flow nearly doubled to reach £62.0m during the period.
Regarding current price levels, authoritative data is unavailable for the close of September 10, 2026, though the qualitative outlook remains focused on future growth catalysts in Latin American markets. Investors are weighing the strong annual performance against cautions of modest growth ahead due to tougher agricultural market conditions. With no major upcoming corporate catalysts listed in the immediate economic calendar, the stock's trajectory will likely depend on the implementation of the newly announced buyback.